International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors.
Lu
Nick Z
NZ
Molecular Endocrinology Group, Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina 27709, USA.
Wardell
Suzanne E
SE
Burnstein
Kerry L
KL
Defranco
Donald
D
Fuller
Peter J
PJ
Giguere
Vincent
V
Hochberg
Richard B
RB
McKay
Lorraine
L
Renoir
Jack-Michel
JM
Weigel
Nancy L
NL
Wilson
Elizabeth M
EM
McDonnell
Donald P
DP
Cidlowski
John A
JA
D000818:Animals; D006727:Hormone Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008024:Ligands; D009154:Mutation; D011944:Receptors, Androgen / Q000235:genetics / Q000502:physiology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000145:classification / Q000235:genetics / Q000502:physiology; D011965:Receptors, Glucocorticoid / Q000235:genetics / Q000502:physiology*; D018161:Receptors, Mineralocorticoid / Q000235:genetics / Q000502:physiology*; D011980:Receptors, Progesterone / Q000235:genetics / Q000502:physiology*
D006727:Hormone Antagonists; D008024:Ligands; D011944:Receptors, Androgen; D018160:Receptors, Cytoplasmic and Nuclear; D011965:Receptors, Glucocorticoid; D018161:Receptors, Mineralocorticoid; D011980:Receptors, Progesterone